3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
6
Terminated
3
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Lung Neoplasms
6
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Squamous Non-small Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Oropharyngeal Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Microsatellite Instability
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large B-Cell, Diffuse
1
Liver Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Breast Cancer Female
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Adenocarcinoma Of Esophagus
1
Interventions
Rituximab
21
Cyclophosphamide
15
Etoposide
11
Vincristine
9
Prednisone
9
Doxorubicin
8
Cytarabine
8
Filgrastim
7
Radiotherapy
6
Peripheral Blood Stem Cell Transplantation
6
fludarabine phosphate
5
Melphalan
5
Dexamethasone
4
Carmustine
4
Bendamustine Hydrochloride
4
loncastuximab tesirine
3
ibrutinib
3
Tacrolimus
3
Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Gemcitabine
3
Calcium Dobesilate
3
CT-P10
3
Busulfan
3
venetoclax
2
sargramostim
2
polatuzumab vedotin
2
pembrolizumab
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Lymphoma, Large B-Cell, Diffuse
×
durvalumab
×
Clear all
NCT03241017
2018-04-09
IDA-D
Insel Gruppe AG, University Hospital Bern
Phase 2
Withdrawn